Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroendocrine differentiation in prostatic malignancy

P A di Sant'Agnese1, A T Cockett

  • 1Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, New York, USA.

Cancer
|July 15, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dysbarism. A review of 35 cases with suggestions for therapy.

Project report. USAF School of Aviation Medicine·2014
Same author

Suppression of the growth and invasiveness of human prostate cancer cells in vitro by neuropeptide antagonist substance P analogues.

Urologic oncology·2011
Same author

Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2.

Cell death and differentiation·2008
Same author

Neuroendocrine differentiation in prostatic carcinoma: an update on recent developments.

Annals of oncology : official journal of the European Society for Medical Oncology·2002
Same author

Transurethral prostatectomy: immediate and postoperative complications. Cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol, 141: 243-247, 1989.

The Journal of urology·2001
Same author

Calcitonin and calcitonin gene-related peptide in the human prostate gland.

The Prostate·2000

Neuroendocrine differentiation in prostate cancer may impact prognosis. Further research is needed to define its role and explore therapeutic implications for better patient outcomes.

Area of Science:

  • Urology
  • Endocrinology
  • Oncology

Background:

  • Prostatic neuroendocrine cells produce serotonin and peptide hormones, forming part of the diffuse neuroendocrine (APUD) system.
  • Focal neuroendocrine differentiation is common in prostate carcinomas.
  • Specific neuroendocrine malignancies include small cell carcinoma and carcinoid tumors.

Purpose of the Study:

  • To review the literature on prostatic neuroendocrine cells and neuroendocrine differentiation in prostate carcinoma.
  • To explore the potential prognostic and therapeutic significance of neuroendocrine differentiation in prostate cancer.

Main Methods:

  • A comprehensive literature review was conducted.
  • Analysis focused on the role of neuroendocrine cells and differentiation in prostate carcinoma.

Related Experiment Videos

Main Results:

  • Neuroendocrine cells likely play a regulatory role in the prostate.
  • Neuroendocrine differentiation may hold prognostic significance in prostate carcinoma.
  • Potential mechanisms include growth factor activity and altered proliferation, independent of androgen receptor expression.

Conclusions:

  • Neuroendocrine differentiation may be prognostically significant in prostate carcinoma.
  • Improved methods are required to accurately define neuroendocrine differentiation.
  • Therapeutic implications warrant further investigation.